The Challenge of Evidence Generation

In the Tuesday morning WFH session on global surveillance and collaboration, Glenn Pierce, explores the challenges of evidence generation.
Essential Medicines List, Orphan Drugs, and Paid Plasma

In the Tuesday morning WFH session on global surveillance and collaboration, Brian O’Mahony, provides his vision for the role of the WFH in ensuring adequate access to a safe supply of hemophilia treatment.
Medical Plenary: Hemophilia treatment in 2030

In the Tuesday morning medical plenary, Erik Berntorp describes his vision of hemophilia treatment and medical advances in 2030.
Porcine Factor VIII

In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.